Antibody fragment therapies are a type of biologic. They are typically fragments of monoclonal antibodies selected to bind to a particular protein (often a cell-surface protein), and produced ...

Every three seconds, someone in the world develops dementia. Alzheimer's disease is the most common form of dementia, accounting for between 60% and ...

These are exciting times for biotech business Complement Therapeutics, which stands on the cusp of an important milestone in ...

Amyloid-beta forms sticky plaques on the outside of brain cells. This disrupts communication between neurons. Tau accumulates inside brain cells, where it twists into tangles. This ultimately leads to ...

Monoclonal antibody drugs have been approved in recent years for this ... Some bacteria form protective communities called biofilms, which rely on amyloid assemblies (similar in structure to the ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be ...